A cylinder hydraulic press has a small piston with a diameter of 3 m, and the diameter of the large piston is unknown. Suppose a force of 800 N is applied onto the small

piston to lift the 250 kg load. The hydraulic press follows Pascal principle.

Calculate the diameter of the large piston.

Dinate system, and a charge q = - 2.00 nc is placed s2 10 n> c. (a) what is the change in electric potential energy when the dipole moment of a molecule changes its orientation with respect to es from parallel to perpendicular? (b) at what absolute temperature t is the average translational kinetic energy 32 kt of a molecule equal to the change in potential energy calculated in part(: abovethistemperature,thermalagitationprevents the dipoles from aligning with the electric field.) placed in a uniform electric field e with magnitude 1.6 * 6 on the positive x-axis at x = 4.00 cm. (a) if a third charge q3 = +6.00 nc is now placed at the point x = 4.00 cm, y = 3.00 cm, find the x- and y-components of the total force exerted on this charge by the other two. (b) find the magnitude and direction of figure p21.62 ll uu 21.55 . torque on a dipole. an electric dipole with dipole moment ps is in a uniform external electric field es. (a) find the orientations of the dipole for which the torque on the dipole is zero. (b) which of the orientations in part (a) is stable, and which is unstable? (hint: consider a small rotation away from the equi- librium position and see what happens.) (c) show that for the stable orientation in part (b), the dipole’s own electric field tends to oppose the external field. 21.62 ..

The material that keeps its new shape after it is stretched is called?

Asubject in a clinical research trial experiences a serious, unanticipated adverse drug experience. how should the investigator proceed, with respect to the irb, after the discovery of the adverse event occurrence? a. do not report the adverse drug experience to the irb since it is a common adverse experience.b. report the adverse drug experience to the irb only if there are several other occurrences.c. report the adverse drug experience as part of the continuing review report.d. report the adverse drug experience in a timely manner, in keeping with the irb's policies and procedures, using the forms or the mechanism provided by the irb.